Codexis (CDXS) Stock Price, Quote, News & History | Benzinga

Codexis (CDXS) Stock Price, Quote, News & History

CDXSNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$1.24

-0.06-4.62%

At close: Jan 30, 4:00 PM EST

$1.24

N/A

After Hours: Jan 30, 4:00 PM EST

Overview

News Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$1.30

Close

$1.24

Volume / Avg.

1.08M / 1.16M

Day Range

$1.22 - $1.30

52 Wk Range

1.25 - 4.68

Market Cap

$112.00M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

31

Short Interest

6.53%

Days to Cover

4.67

Recent Codexis Inc News

Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

Avi Kapoor

Codexis Clinches Deal With Nestlé Health Science, Eyes Up To $45M Milestone In EPI Treatment Breakthrough

Codexis, Inc. (NASDAQ: CDXS) entered a purchase deal with Nestlé S.A.(OTC: NSRGY) Nestlé Health Science for CDX-7108, a potential treatment for exocrine pancreatic insufficiency (EPI).

Akanksha Bakshi

Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales guidance below estimates.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-55.94M

Investing Cash Flow (TTM)

14.93M

Financing Cash Flow (TTM)

28.88M

Free Cash Flow (TTM)

-61.66M

Capital Expenditure (TTM)

-5.73M

Net Change in Cash (TTM)

-12.13M

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$122.83M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.07

PB Ratio (TTM)

3.02

Earnings Yield % (TTM)

-56.59%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.43

Company Debt

Total Debt

$39.73M

LT Debt

$39.73M

LT Debt Issuance (TTM)

$9.90M

LT Debt Repayment (TTM)

-

Total Cash

$25.35M

Debt to Equity

1.78

Issuance of Debt (TTM)

$9.90M

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.30

Close

$1.24

Volume / Avg.

1.08M / 1.16M

Day Range

$1.22 - $1.30

52 Wk Range

1.25 - 4.68

Market Cap

$112.00M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

31

Short Interest

6.53%

Days to Cover

4.67

About

Sector

Health Care

Industry

Life Sciences Tools & Services

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes s...

Show More

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Codexis (CDXS) stock?

A

You can purchase shares of Codexis (NASDAQ:CDXS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Codexis (CDXS) competitors?

A

Other companies in Codexis’s space includes: Harvard Bioscience Inc (NASDAQ:HBIO), CryoPort Inc (NASDAQ:CYRX), Mesa Laboratories Inc (NASDAQ:MLAB), Quantum-Si Inc (NASDAQ:QSI) and Inotiv Inc (NASDAQ:NOTV).

Q

What is the forecast, or price target, for Codexis (CDXS) stock?

A

Codexis has a consensus price target of $8.00.

Q

What is the current price for Codexis (CDXS)?

A

The stock price for Codexis (NASDAQ: CDXS) is $1.24 last updated January 30, 2026 at 4:00 PM EST.

Q

Does Codexis (CDXS) pay a dividend?

A

There are no upcoming dividends for Codexis.

Q

When is Codexis (NASDAQ:CDXS) reporting earnings?

A

Codexis does not have any upcoming earnings scheduled.

Q

Is Codexis (CDXS) going to split?

A

There is no upcoming split for Codexis.

Q

What sector and industry does Codexis (CDXS) operate in?

A

Codexis is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

People Also Watch

Harvard Bioscience Inc

Mesa Laboratories Inc

Lifecore Biomedical Inc

Atlantic International Corp

Bionano Genomics Inc